Ewha W.UEwha W.U

Open Search
Search
Open Mobile Menu

Ewha W.U

Search
nav bar
 

News Center

EWHA NEWS

Ewha Starts to Co-develop AI Platform for Cardiotoxicity Evaluation of New Drug Candidates with Fraunhofer IBMT, Germany
Ewha Starts to Co-develop AI Platform for Cardiotoxicity Evaluation of New Drug Candidates with Fraunhofer IBMT, Germany Ewha Starts to Co-develop AI Platform for Cardiotoxicity Evaluation of New Drug Candidates with Fraunhofer IBMT, Germany Ewha has been selected for the “2025 Korea-Germany Industry-Academia Joint Research (2+2 Projects),” overseen by the Ministry of Science and ICT, in collaboration with the Fraunhofer Institute for Biomedical Engineering (IBMT), a world-renowned applied science research institute in Germany. Based on its selection for this large-scale global research project, which is jointly supported by the governments of both nations, Ewha plans to further strengthen scientific and technological cooperation between Korea and Germany. To this end, Jang-Hwan Choi, professor at the Department of Artificial Intelligence at Ewha, and Heiko Zimmermann, director of Fraunhofer IBMT, Germany, have secured a total of KRW 1.87 billion in research funding to jointly develop a next-generation drug cardiotoxicity evaluation platform that combines 3D myocardial organoids and AI over a period of three years starting this October. The contractile dynamics of iPSC-based 3D myocardial organoids are measured with Fraunhofer IBMT’s non-contact optical metrology technology in real time and analyzed with unsupervised AI models from the Medical AI & Computer Vision Lab at Ewha to automatically generate drug dose-response curves. This is expected to enable the high-speed and high-precision prediction of cardiotoxicity risk for new drug candidates at the preclinical stage. To this end, the two organizations signed an MOU in April and established the Ewha–Fraunhofer RegMed AI Hub in Seoul. The Korean Fund for Regenerative Medicine (KFRM) stated that the collaboration will serve as an opportunity to enter the drug development market and establish a global standard platform. The research participants include Ewha Womans University (general management and AI development), Biosolvix Co., Ltd. (organoid production and standardization), Korea University College of Medicine (histopathology and clinical consulting), Dt & CRO (preclinical verification), Fraunhofer IBMT (optical metrology and stem cell platform), and Innovitro GmbH (3D culture process). In particular, Biosolvix will promote the commercialization of research outcomes while carrying out projects of the KFRM. This collaboration was enabled through researcher exchange support projects by the KFRM, including the hosting of an international workshop in 2026, plans for the AI-Organoid Cardiotoxicity Challenge in 2027, completion of preclinical validation, and technology transfer for domestic and foreign pharmaceutical companies and CROs by 2028. Through such efforts, Korea and Germany are expected to strengthen cooperation in the fields of advanced regenerative medicine and AI-digital healthcare convergence, and lead global innovation in cardiotoxicity evaluation.
Ewha College of Business Administration and Graduate School of Business to Achieve Fourth Consecutive AACSB Accreditatio
Ewha College of Business Administration and Graduate School of Business to Achieve Fourth Consecutive AACSB Accreditatio Ewha College of Business Administration and Graduate School of Business to Achieve Fourth Consecutive AACSB Accreditation The College of Business Administration and the Graduate School of Business at Ewha have been accredited for the fourth consecutive time from the Association to Advance Collegiate Schools of Business (AACSB), a global accreditation body for business education. In 2010, Ewha became the first women’s university in the world to receive accreditation across the entire cycle across undergraduate, graduate, and MBA programs. Following the two reaccreditations (2015-2020 and 2020-2025), this latest renewal extends Ewha’s accreditation status to 2025-2030. The AACSB provides the highest level of accreditation for business education, awarding only the top five percent of around 16,000 business schools worldwide. Ewha Womans University is the only women’s comprehensive university to receive accreditation for all stages of business education from undergraduate to graduate level. In an on-site evaluation conducted last May, Ewha was highly rated for its research capacity, globalization, curriculum, and infrastructure. Since its founding in 1964, the College of Business Administration at Ewha has aimed to cultivate global female business executives capable of demonstrating exceptional practical skills in various fields of business management. To this end, the College has developed and offered integrated courses and programs that maximize connectivity with other majors. In line with these endeavors, the College established master’s and doctoral programs in AI & Business Analytics within the Graduate School in 2025 to offer a convergence education in AI and business analytics. Based on this specialized strategy tailored to female leadership and practical training, the College is leading the way in fostering world-class female executives. Launched in 2006 based on its expertise and network in fostering female talent, the Graduate School of Business Administration at Ewha (hereinafter Ewha GSBA) offers a curriculum that combines cutting-edge business theory with a case-oriented education system. It also offers a full-time doctoral program (Doctor of Business Administration, DBA) that teaches scientific management theory and methodology to business managers with extensive practical experience in the field. Notably, the DBA program at the Ewha GSBA, the first of its kind in Korea, cultivates “professionals who can proactively lead changes and innovation” by acquiring the skills necessary to seek innovative management solutions in business environments.
READ MORE

Notice & Event Information

August Event

MORE

Social Network Service

EWHA SNS

  • Instagram Youtube